Article Details
Retrieved on: 2021-05-12 13:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The brokerage currently has a "buy" rating on the medical research company's stock. Truist Securities' price target indicates a potential upside of 71.43% ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here